THYROCARE TECHNOLOGIES
Back to Cashflow Statement
|
THYROCARE TECHNOLOGIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-130 Cr | ₹-85 Cr | ₹-86 Cr | ₹-89 Cr | ₹-62 Cr |
What is the latest Cash Flow from Financing Activities ratio of THYROCARE TECHNOLOGIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-130 Cr |
| Mar2024 | ₹-85 Cr |
| Mar2023 | ₹-86 Cr |
| Mar2022 | ₹-89 Cr |
| Mar2021 | ₹-62 Cr |
How is Cash Flow from Financing Activities of THYROCARE TECHNOLOGIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-130 Cr | Negative | |
| Mar2024 | ₹-85 Cr | Negative | |
| Mar2023 | ₹-86 Cr | Negative | |
| Mar2022 | ₹-89 Cr | Negative | |
| Mar2021 | ₹-62 Cr | - | |
Compare Cash Flow from Financing Activities of peers of THYROCARE TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| THYROCARE TECHNOLOGIES | ₹5,618.2 Cr | 1.3% | -14.6% | 59.8% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹105,872.0 Cr | -3.8% | -4.4% | 22.4% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹93,883.2 Cr | -3.7% | -11.4% | -1.1% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹62,019.8 Cr | -2.4% | -9.6% | 39.8% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹33,776.8 Cr | -1.3% | -9.9% | 9.7% | Stock Analytics | |
| GLOBAL HEALTH | ₹27,013.4 Cr | -5.4% | -13.6% | -11.2% | Stock Analytics | |
THYROCARE TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THYROCARE TECHNOLOGIES | 1.3% |
-14.6% |
59.8% |
| SENSEX | -0% |
-10.7% |
1% |
You may also like the below Video Courses